Fundraising Fox
/Companies
Sign in

Olio Labs

YC S23

Founded 2023 · 5 employees · 6 known investors

Find your way into Olio Labs

Sign up to see every warm intro you have to Olio Labs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Olio Labs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Olio Labs develops drug combination therapies using machine learning to identify treatments that target multiple interacting proteins simultaneously, with initial candidates focused on obesity treatment. The company aims to create pharmaceutical solutions that achieve greater efficacy and lower side effect profiles than existing single-target medications.

BiotechHealthtechFully Remote

Founders & leadership· Y Combinator alumni (S23)

Olio Labs was founded in 2023 by David Tingley and Tom Roseberry.

DTDavid Tingley
David TingleyFounderDavid Tingley holds a PhD in Neuroscience from New York University and completed postdoctoral research at Harvard Medical School. He has over 13 years of experience in systems neuroscience and biology, with published research on the relationship between neural oscillations and metabolic processes.
TRTom Roseberry
Tom RoseberryCo-Founder & CTOTom Roseberry has 15+ years of experience in aerospace, neural interface development, and drug discovery. He previously served as VP of Engineering at Loyal overseeing computational biology and drug development teams, and at Neuralink led a group developing neural interface technology.
TK
Tim KrauszLead Research Engineer

Investors · 6

Pioneerlisted by PioneerToronto, Ontario

How we know: pioneerfund.vc · open dataset · 5k.vc investor directory · Not right? Tell us

SciFounderslisted by SciFoundersSan Francisco · $1M

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Scrum Ventureslisted by Scrum VenturesSan Francisco

How we know: Scrum Ventures's portfolio page · funding news · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

ZAKA VClisted by ZAKA VCSan Francisco

Related companies · 5

OlioOlio provides care coordination technology for post-acute and behavioral health organizations, automatically connecting care teams across SNFs, behavioral health providers, payers, health systems, home health, and hospice to improve outcomes and reduce costs.
OlioappOlio is a local sharing app that enables users to give away and receive surplus food and household items with neighbors. The platform addresses food waste and promotes reuse of goods within communities.
ElioElio develops adaptive sensors that enable AI systems to dynamically select information at variable resolutions and dimensions, giving machine intelligence direct perception capabilities for physical world applications.
Aulos BioscienceAulos develops an immune-activating monoclonal antibody therapeutic for cancer, using AI to design an antibody targeting the IL-2 portion that interacts with the CD25 receptor to shift IL-2 activity toward immune activation. Its lead investigational candidate, imneskibart, is in a Phase 1/2 clinical trial for solid tumor cancers including melanoma and renal cell carcinoma.
Altos LabsAltos Labs develops computational and scientific approaches to reverse disease through breakthrough medicines, operating research institutes focused on cell health, computation, and drug discovery.

Companies working in the same space as Olio Labs.

Legal entities · 1

corporate structure
Olio Labs Incorporated

In the news

Olio Labs Raises $4.5M Funding | citybizcitybiz.co · Mar 2025Olio Labs - Combination therapeutics for the world's toughest diseasesycombinator.com · Aug 2023

Frequently asked questions

What does Olio Labs do?
Olio Labs develops drug combination therapies using machine learning to identify treatments that target multiple interacting proteins simultaneously, with initial candidates focused on obesity treatment. The company aims to create pharmaceutical solutions that achieve greater efficacy and lower side effect profiles than existing single-target medications.
Who founded Olio Labs?
Olio Labs was founded by David Tingley, Tom Roseberry in 2023.
Who are Olio Labs's investors?
Olio Labs's investors include Overwater Ventures Llc, Pioneer, SciFounders, Scrum Ventures, Y Combinator, ZAKA VC.